Citigroup’s Darling Ingredients DAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-18,500
Closed -$966K – 5729
2023
Q3
$966K Buy
+18,500
New +$1.16M ﹤0.01% 2545
2023
Q1
– Sell
-29,400
Closed -$1.84M – 5567
2022
Q4
$1.84M Buy
+29,400
New +$2.07M ﹤0.01% 2106
2019
Q1
– Sell
-100
Closed -$2K – 7674
2018
Q4
$2K Sell
100
-700
-88% -$14.2K ﹤0.01% 7498
2018
Q3
$15K Sell
800
-10,200
-93% -$201K ﹤0.01% 7204
2018
Q2
$219K Sell
11,000
-100
-0.9% -$1.81K ﹤0.01% 4977
2018
Q1
$192K Buy
11,100
+3,500
+46% +$63.6K ﹤0.01% 5007
2017
Q4
$138K Buy
7,600
+3,100
+69% +$53.6K ﹤0.01% 5351
2017
Q3
$79K Buy
4,500
+600
+15% +$10.2K ﹤0.01% 5735
2017
Q2
$61K Buy
3,900
+1,900
+95% +$29.4K ﹤0.01% 5663
2017
Q1
$29K Buy
2,000
+1,500
+300% +$19.8K ﹤0.01% 6059
2016
Q4
$6K Buy
+500
New +$6.77K ﹤0.01% 6867
2016
Q2
– Sell
-5,300
Closed -$70K – 7126
2016
Q1
$70K Hold
5,300
– – ﹤0.01% 5910
2015
Q4
$56K Buy
+5,300
New +$55.2K ﹤0.01% 5848

Other funds holding DAR

Citigroup's DAR Position: Q3 2026 in Review

Citigroup reduced its Darling Ingredients (DAR) stake by 26% in Q3 2026, selling an estimated $7.6M and leaving 342,543 shares worth $20.8M. The position accounts for 0.01% of the portfolio, ranked #1174.

Citigroup first reported a position in DAR in Q2 2013 and has held it in 54 quarters since. The position peaked at $52M in Q1 2022. 363 funds tracked by Wall St. Rank hold DAR as of Q3 2026.

  • Citigroup held 342,543 shares of Darling Ingredients worth $20.8M as of Q3 2026.
  • Citigroup sold 120,813 Darling Ingredients shares in Q3 2026, an estimated $7.6M.
  • Darling Ingredients made up 0.01% of Citigroup's portfolio in Q3 2026, its #1174 holding.
  • Citigroup first reported a position in Darling Ingredients in Q2 2013 and has held it in 54 quarters since.
  • Citigroup's Darling Ingredients position peaked at $52M in Q1 2022.
  • 363 funds tracked by Wall St. Rank held Darling Ingredients as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.